Preferred Name |
pegfilgrastim |
|
Synonyms |
PEG SD-01 |
|
ID |
http://purl.bioontology.org/ontology/MESH/C455861 |
|
altLabel |
PEG SD-01 lipegfilgrastim SD-01-filgrastim XM22 N-(3-hydroxypropyl)methionylcolony-stimulating factor (human), 1-ether with alpha-methyl-omega-hydroxypoly(oxyethylene) PEG-rmetHuG-CSF XM-22 Neulasta SD-01, polyethylene glycol-conjugated filgrastim LA-EP2006 |
|
cui |
C5441855 C1171279 C3640212 C4083253 C3641684 C1136535 |
|
HM |
D011092 D000069585 |
|
Inverse of RB |
4AWF0N6QV3 3A58010674 0 |
|
LT |
TRD |
|
Mapped to | ||
MDA |
20020606 |
|
MeSH Frequency |
702 |
|
MMR |
20180924 |
|
notation |
C455861 |
|
prefLabel |
pegfilgrastim |
|
RR |
4AWF0N6QV3 |
|
SC |
1 |
|
Scope Statement |
pegylated (r-G-CSF) conjugated to polyethylene glycol for treatment of neutropenic patients with non-myeloid malignancies who are at high risk for infection |
|
SRC |
Med Lett Drugs Ther 2002 May 13;44(1130):44-5 |
|
TERMUI |
T000916839 T419953 T000901411 T496970 T419952 T835028 T835029 T000946982 T595111 T419954 T496969 |
|
TH |
US NLM (2016) NLM (2002) NLM (2004) NLM (2000) FDA SRS (2017) USAN (2004) USAN (19XX) INN (19XX) DE NLM (2017) FDA SRS (2012) NLM (2014) |
|
tui |
T116 T129 T121 |